A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer
Clinical trial NCT03632941 · TERMINATED
Trial details
- NCT number
- NCT03632941
- Sponsor
- Herbert Lyerly
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2023-09-03
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.